Earnings
BIOL
0.1410
+1.51%
0.0021
Currencies: USD
Items
Net Income
Depreciation and Amortization
Deferred Tax
Unamortized Expenditures
Accrued Expenses
Share-based Compensation
Assets Disposal
Financial Expenses
Investment Loss
Working Capital Change
Other Items
Operating Activities
Purchases of Fixed Assets
Proceeds from Disposal of Fixed Assets
Investment Expenditure
Investment Income
Other Investing Activities
Investing Activities
Issuance of Capital Stock
Issuance of Bonds
Proceeds from Borrowings
Dividend Payments
Repayment of Borrowings
Buyback Payments
Stock Incentive Compensation
Other Financing Activities
Financing Activities
Effect of Exchange Rate Changes 
Net Increase in Cash,Cash Equivalents
FY 2021-12-31
-16.16M
400.00K
--
--
--
--
985.00K
--
--
-1.94M
--
-16.71M
-707.00K
--
--
--
--
-707.00K
31.11M
-25.00K
--
--
--
--
--
--
29.95M
-238.00K
12.30M
FY 2020-12-31
-16.83M
499.00K
0.00
--
--
--
1.78M
--
--
1.75M
--
-12.79M
-96.00K
--
--
--
--
-96.00K
24.96M
2.44M
--
--
--
--
--
--
24.35M
317.00K
11.78M
FY 2019-12-31
-17.86M
982.00K
7000.00
--
--
--
5.23M
--
--
-1.11M
--
-12.75M
-207.00K
--
--
--
0.00
-207.00K
9.18M
2.50M
--
--
--
--
--
--
10.72M
-23.00K
-2.25M
FY 2018-12-31
-21.52M
945.00K
-27.00K
--
--
--
6.46M
--
--
-9000.00
--
-14.15M
-558.00K
--
--
--
36.00K
-522.00K
3000.00
12.45M
--
--
--
--
--
--
11.23M
-106.00K
-3.54M
FY 2017-12-31
-16.85M
1.20M
-694.00K
--
--
--
3.33M
--
--
-5.40M
--
-18.41M
-747.00K
--
--
--
0.00
-747.00K
21.76M
-146.00K
--
--
--
--
--
--
21.62M
262.00K
2.72M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.